论文部分内容阅读
胃癌的发病率在当前世界恶性肿瘤中占第4位,病死率占恶性肿瘤的第2位。在我国,多数胃癌患者确诊时已是进展期,而部分有远处转移。肝脏是胃癌血行转移的第一靶器官,胃癌肝转移的总体发生率可达4%~14%[1-3]。胃癌肝转移预后差,中位生存期不足6个月,5年生存率低于10%[4]。在治疗上,目前对于胃癌肝转移还没有标准的治疗方案。美国国立综合癌症网络(NCCN)推荐对转移性胃癌
The incidence of gastric cancer in the current world of malignant tumors in the No. 4, case fatality rate of malignant tumors ranked No. 2. In our country, the majority of patients with gastric cancer have been diagnosed with advanced stage, while some have distant metastasis. Liver is the first target organ of gastric cancer blood metastasis, the overall incidence of gastric cancer liver metastases up to 4% to 14% [1-3]. Poor prognosis of liver metastases of gastric cancer, the median survival of less than 6 months, 5-year survival rate of less than 10% [4]. In the treatment, there is no standard treatment for liver metastasis of gastric cancer. The National Comprehensive Cancer Network (NCCN) recommends metastatic gastric cancer